CLINICAL_TRIALS
trial_result
· 2021-02-02
Clinical Trial Update: Open-label Extension Study Of RN624 [Phase 2]
Summary
Open-label extension study update for RN624 in phase 2 in osteoarthritis and knee pain.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Pfizer | Conditions: Osteoarthritis, OA Knee Pain | Phase 2 | Status: COMPLETED | Results posted: 2021-02-02